Concepedia

Fengtian Xue

FX

Statistics

Publications

65

Citations

2.2K

H-Index

27

Active since

2005

Affiliations

University of Maryland, Baltimore(Current)

Northwestern University

University of California, Irvine

The University of Texas at San Antonio Health Science Center

Charles University

Fengtian Xue is an author at University of Maryland, Baltimore specializing in drug discovery, pharmacology, and medicinal chemistry.

ORCID

Publications per year

2005–2022

65

Publications

65

A Hybrid Mechanism of Action for BCL6 in B Cells Defined by Formation of Functionally Distinct Complexes at Enhancers and Promoters

Katerina Hatzi, Yanwen Jiang, Chuanxin Huang et al. · Cell Reports · 2013 · 196 citations · Full text

, , +17

Rationally designed BCL6 inhibitors target activated B cell diffuse large B cell lymphoma

Mariano Cárdenas, Wenbo Yu, Wendy Béguelin et al. · Journal of Clinical Investigation · 2016 · 172 citations · Full text

, , +17

Discovery of novel N-substituted carbazoles as neuroprotective agents with potent anti-oxidative activity

Daqian Zhu, Meihui Chen, Min Li et al. · European Journal of Medicinal Chemistry · 2013 · 93 citations

, , +13

Novel LRRK2 GTP-binding inhibitors reduced degeneration in Parkinson's disease cell and mouse models

T. Li, Dongqing Yang, Shan Zhong et al. · Human Molecular Genetics · 2014 · 91 citations

, , +17

Novel mGluR5 Positive Allosteric Modulator Improves Functional Recovery, Attenuates Neurodegeneration, and Alters Microglial Polarization after Experimental Traumatic Brain Injury

David J. Loane, Bogdan A. Stoica, Flaubert Tchantchou et al. · Neurotherapeutics · 2014 · 80 citations · Full text

, , +16

1–5 of 65